Home
All Journals
Expert Opinion on Pharmacotherapy
List of Issues
Volume 16, Issue 9

Expert Opinion on Pharmacotherapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Expert Opinion on Pharmacotherapy, Volume 16, Issue 9 (2015)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Pharmacotherapy, Volume 16, Issue 9 (2015)

See all volumes and issues

Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Volume 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 1999-2000

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Should patients in need be given access to experimental drugs?

Arthur L Caplan (William F and Virginia Connolly Mitty Chair, Director) PhD & Alison Bateman-House (Rudin Postdoctoral Fellow) PhD MPH MA

Pages: 1275-1279

Published online: 22 May 2015

AbstractforShould patients in need be given access to experimental drugs? | Full Text | References | PDF (146.4 KB)

11354 Views
35 CrossRef citations
0Altmetric

Free Access

Editorial

How can we improve prognostic models in renal cell carcinoma?

Carlo Buonerba, Matteo Ferro, Francesco Perri, Giuseppe Calderoni, Pina Mambella, Pasqualina Giordano, Prisco Piscitelli, Vittorino Montanaro, Michele Aieta & Giuseppe Di Lorenzo

Pages: 1281-1283

Published online: 22 May 2015

AbstractforHow can we improve prognostic models in renal cell carcinoma? | Full Text | References | PDF (128 KB)

565 Views
3 CrossRef citations
0Altmetric

Free Access

Review

BRAF and MEK inhibition for the treatment of advanced BRAF mutant melanoma

Juliet Richman, Juan Martin-Liberal, Stefan Diem & James Larkin

Pages: 1285-1297

Published online: 22 May 2015

AbstractforBRAF and MEK inhibition for the treatment of advanced BRAF mutant melanoma | Full Text | References | PDF (242.3 KB)

925 Views
22 CrossRef citations
0Altmetric

Pharmacologic therapy for Peyronie’s disease: what should we prescribe?

Benjamin A Sherer MD, Karl F Godlewski & Laurence A Levine MD

Pages: 1299-1311

Published online: 30 Apr 2015

AbstractforPharmacologic therapy for Peyronie’s disease: what should we prescribe? | Full Text | References | PDF (312.6 KB)

218 Views
3 CrossRef citations
0Altmetric

HIV integrase inhibitors: a new era in the treatment of HIV

Jose Luis Blanco MD PhD, Gary Whitlock MD, Ana Milinkovic MD PhD & Graeme Moyle MD PhD

Pages: 1313-1324

Published online: 22 May 2015

AbstractforHIV integrase inhibitors: a new era in the treatment of HIV | Full Text | References | PDF (249.5 KB)

1370 Views
49 CrossRef citations
0Altmetric

Recent advances in glucose-lowering treatment to reduce diabetic kidney disease

Nordin MJ Hanssen, Nicholas Russell & Mark E Cooper MBBS PhD FRACP

Pages: 1325-1333

Published online: 26 Apr 2015

AbstractforRecent advances in glucose-lowering treatment to reduce diabetic kidney disease | Full Text | References | PDF (242.8 KB)

522 Views
6 CrossRef citations
0Altmetric

Antipsychotic use in pregnancy

Jayashri Kulkarni (Director) , Adele Storch, Analin Baraniuk, Heather Gilbert, Emmy Gavrilidis & Roisin Worsley

Pages: 1335-1345

Published online: 22 May 2015

AbstractforAntipsychotic use in pregnancy | Full Text | References | PDF (241.1 KB)

2738 Views
40 CrossRef citations
0Altmetric

An update on pharmacotherapy for the treatment of fibromyalgia

Elena P Calandre, Fernando Rico-Villademoros & Mahmoud Slim

Pages: 1347-1368

Published online: 22 May 2015

AbstractforAn update on pharmacotherapy for the treatment of fibromyalgia | Full Text | References | PDF (385 KB)

2099 Views
72 CrossRef citations
0Altmetric

Polycystic ovary syndrome: chemical pharmacotherapy

Morena Luigia Rocca MD, Roberta Venturella MD, Rita Mocciaro MD, Annalisa Di Cello MD, Angela Sacchinelli MD, Valentina Russo MD, Simona Trapasso MD, Fulvio Zullo PhD & Michele Morelli PhD

Pages: 1369-1393

Published online: 22 May 2015

AbstractforPolycystic ovary syndrome: chemical pharmacotherapy | Full Text | References | PDF (685.1 KB)

668 Views
30 CrossRef citations
0Altmetric

Drug Evaluation

Vosaroxin is a novel topoisomerase-II inhibitor with efficacy in relapsed and refractory acute myeloid leukaemia

Anya K Hotinski BSc (Hons) BMBS, Ian D Lewis (Associate Professor, Clinical Director of Haematology) MBBS PhD FRACP FRCPA & David M Ross (Consultant Haematologist) MBBS PhD FRACP FRCPA

Pages: 1395-1402

Published online: 10 May 2015

AbstractforVosaroxin is a novel topoisomerase-II inhibitor with efficacy in relapsed and refractory acute myeloid leukaemia | Full Text | References | PDF (197.3 KB)

352 Views
13 CrossRef citations
0Altmetric

Tiotropium bromide as add-on therapy to inhaled corticosteroids for treating asthma

Hiroto Matsuse MD PhD, Tohru Yamagishi MD, Norio Kodaka MD, Atsuo Miura MD, Yoshiyuki Kurose MD, Chihiro Nakano MD PhD & Takeshi Oshio MD

Pages: 1403-1409

Published online: 22 May 2015

AbstractforTiotropium bromide as add-on therapy to inhaled corticosteroids for treating asthma | Full Text | References | PDF (324.3 KB)

429 Views
3 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Effect of ipragliflozin on liver enzymes in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials

Rizwana Parveen et al.

Review Article | Published online: 28 May 2024

Promising immunomodulators for management of substance and alcohol use disorders

Amanda M. Acuña et al.

Review Article | Published online: 28 May 2024

Revolutionizing hepatitis C treatment: next-gen direct-acting antivirals

Krystyna Dobrowolska et al.

Review Article | Published online: 27 May 2024

Recent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulants

Ann Childress

Review Article | Published online: 27 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Pharmacotherapy (Vol.16, Iss.9, 2015)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?